News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Aileron Therapeutics Appoints Experienced Drug Developer, Anthony M. Manning, Ph.D., to Senior Vice President of Research and Preclinical Development


4/12/2011 8:50:20 AM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aileron Therapeutics, Inc., a biopharmaceutical company that has defined a new class of drugs called Stapled Peptides, today announced the appointments of Anthony M. Manning, Ph.D., to senior vice president of research and preclinical development and Yong S. Chang, Ph.D., to head of biology. These strategic appointments come as Aileron continues to advance several drug development programs utilizing its Stapled Peptide™ technology.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES